FIELD: pharmaceuticals.
SUBSTANCE: invention refers to pharmacogenetics and personalized medicine. Disclosed is a method of analysing polymorphous markers in the SLCO1B1, APOE and ABCB1 genes to determine individual sensitivity to statins, comprising the following steps: amplification by multiplex single-step PCR, providing a biochip, hybridising the fluorescent labeled PCR product on the biochip and recording and interpreting the hybridisation results.
EFFECT: invention provides detecting the following polymorphous markers: SLCO1B1 (rs4149056, rs4149015), APOE (rs7412), ABCB1 (rs2032582).
1 cl, 2 dwg, 2 tbl, 4 ex
             
         
            
              
                | Title | Year | Author | Number | 
							
              
                | METHOD OF ANALYZING POLYMORPHIC MARKERS IN THE GENES VKORC1, CYP4F2, CYP2C9, CYP2C19, ABCB1, ITGB3 TO DETERMINE INDIVIDUAL SENSITIVITY TO ANTICOAGULANT DRUGS | 2018 | 
										Ikonnikova Anna YurevnaNasedkina Tatyana VasilevnaZasedatelev Aleksandr Sergeevich | RU2689400C1 | 
							
              
                | METHOD OF DETERMINING POLYMORPHIC MARKERS IN CYP2C19 AND CYP2D6 GENES FOR DETERMINING INDIVIDUAL SENSITIVITY TO ANTIDEPRESSANTS | 2018 | 
										Ikonnikova Anna YurevnaPozhitnova Viktoriya OlegovnaNasedkina Tatyana VasilevnaZasedatelev Aleksandr Sergeevich | RU2716589C1 | 
							
              
                | SET OF OLIGONUCLEOTIDE PRIMERS AND PROBES FOR GENETIC TYPING OF POLYMORPHOUS DNA LOCI ASSOCIATED WITH A RISK OF PROGRESSION OF SPORADIC FORM OF ALZHEIMER'S DISEASE IN RUSSIAN POPULATIONS | 2014 | 
										Nasedkina Tatyana VasilevnaGra Olga AlekseevnaNizamutdinov Igor IgorevichZasedatelev Aleksandr Sergeevich | RU2600874C2 | 
							
              
                | METHOD FOR DETERMINING GENETIC MARKERS FOR ASSESSING POLYGENIC RISK OF DEVELOPING HORMONE-POSITIVE SUBTYPE OF BREAST CANCER | 2020 | 
										Ikonnikova Anna YurevnaNasedkina Tatyana Vasilevna | RU2753002C1 | 
							
              
                | METHOD FOR IDENTIFICATION OF GENETIC POLYMORPHISMS AFFECTING METABOLISM OF ANTICANCER DRUGS USING BIOLOGICAL MICROCHIPS | 2018 | 
										Gejdarov Rustam Nuraddin OglyMikhajlovich Vladimir MikhajlovichPopov Anatolij YurevichTitov Sergej VladimirovichEmelyanova Marina AleksandrovnaShaskolskij Boris LeonidovichZasedatelev Aleksandr Sergeevich | RU2697096C1 | 
							
              
                | METHOD FOR DETERMINING GENETIC MARKERS FOR ASSESSING POLYGENIC RISK OF BREAST CANCER (HORMONE-NEGATIVE AND HORMONE-POSITIVE SUBTYPES) | 2020 | 
										Ikonnikova Anna YurevnaNasedkina Tatyana VasilevnaZasedatelev Aleksandr Sergeevich | RU2749465C1 | 
							
              
                | METHOD FOR ANALYSING GENETIC POLYMORPHISM FOR DETERMINING DISPOSITION TO SCHIZOPHRENIA AND ALCOHOLISM | 2012 | 
										Nasedkina Tat'Jana Vasil'EvnaGra Ol'Ga AlekseevnaNizamutdinov Igor' IgorevichGalaktionova Dar'Ja Jur'EvnaLysov Jurij PetrovichZasedatelev Aleksandr Sergeevich | RU2565036C2 | 
							
              
                | BIOLOGICAL MICROCHIP WITH PRIMER SET FOR ANALYSIS OF POLYMORPHISM IN AB0, HLA-DQA1, AMEL, DARC, NAT2 GENES | 2014 | 
										Fesenko Denis OlegovichKornienko Aleksandra EvgenevnaNasedkina Tatjana VasilevnaZasedatelev Aleksandr Sergeevich | RU2582216C2 | 
							
              
                | METHOD FOR IDENTIFYING CHROMOSOMAL TRANSLOCATIONS LEADING TO THE DEVELOPMENT OF MALIGNANT BLOOD DISEASES (LEUKOSES), DUE TO APPLYING OLIGONUCLEOTIDE BIOLOGICAL MICROCHIP (BIOCHIP) | 2004 | 
										Mirzabekov Andrej Dar'EvichNasedkina Tat'Jana Vasil'EvnaZharinov Vladislav SergeevichIsaeva Ekaterina Aleksandrovna | RU2286798C2 | 
							
              
                | METHOD FOR ANALYSIS OF GENETIC POLYMORPHYSM, DEFINING PREDISPOSITION TO TUMOR DISEASES AND INDIVIDUAL SENSITIVITY TO PHARMACEUTICAL AGENTS BY USING OLYGONUCLEOTIDE BIOLOGICAL MICROARRAY (BIOARRAY) | 2005 | 
										Zasedatelev Aleksandr SergeevichNasedkina Tat'Jana Vasil'EvnaGlotov Andrej Sergeevich | RU2303634C2 |